ArticleeLife2019

Targeting the vascular-specific phosphatase PTPRB protects against retinal ganglion cell loss in a pre-clinical model of glaucoma.

Benjamin R Thomson et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.